Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis
Article in Virology Journal (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination
Article in Frontiers in Immunology (January 2024)
Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence
Article in Frontiers in Immunology (November 2023)